Cartesian Therapeutics, Inc.RNACNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank36
Studio
Year-over-Year Change

Price-to-book ratio

Percentile
P36
Within normal range
vs 3Y Ago
-1x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
2025-1.48+97.8%
2024-68.21-29437.7%
2023-0.23-115.9%
20221.45-89.5%
202113.79+197.2%
2020-14.19-231.9%
201910.76+217.4%
2018-9.16-384.2%
20173.22+18.1%
20162.73-